Percentage of Mycoplasma Pneumoniae Infections Up Since September 2023
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 22, 2024 -- The percentage of Mycoplasma pneumoniae infections decreased during the pandemic, but has increased since September 2023, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Chris Edens, Ph.D., from the CDC in Atlanta, and colleagues used data from the CDC National Syndromic Surveillance Program (NSSP) to compare the percentage of M. pneumoniae-related diagnoses among all pneumonia emergency department visits before (January 2018 to April 2020), during (May 2020 to August 2023), and after (September 2023 to December 2023) the COVID-19 pandemic. In addition, during the same period, data from the New Vaccine Surveillance Network (NVSN) were analyzed to compare the percentage of positive M. pneumoniae laboratory test results in the United States.
The researchers observed a decrease in the percentage of M. pneumoniae-related diagnoses among pneumonia emergency department visits reported in NSSP, from 1.15 to 0.35 percent during the prepandemic period and pandemic period, respectively; this was followed by an increase to 0.89 percent during the postpandemic period. The corresponding percentage of laboratory test results within the NVSN that were positive for M. pneumoniae decreased from 1.2 to 0.04 percent and then increased to 0.53 percent. Thirteen of 14 M. pneumoniae-positive specimens that were tested for macrolide resistance during September 2023 to January 2024 were susceptible to macrolides.
"Providers should consider M. pneumoniae as part of the differential diagnosis for cases of community-acquired pneumonia during fall and winter respiratory illness seasons," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Further Support and Information on COVID-19
Read this next
Inappropriate Diagnosis of Pneumonia Common in Hospitalized Adults
WEDNESDAY, March 27, 2024 -- Inappropriate diagnosis of community-acquired pneumonia (CAP) in hospitalized adults is common, especially among older adults and those with dementia...
Physicians ID Barriers to 'No Antibiotic' Strategy for Pediatric Viral Pneumonia
THURSDAY, Jan. 18, 2024 -- There are considerable barriers relating to implementation of a "no antibiotic" strategy for mild community-acquired pneumonia (CAP) in children...
Liquefied Petroleum Gas Does Not Affect Severe Pneumonia Risk in Infants
THURSDAY, Jan. 4, 2024 -- An intervention that replaces biomass fuel (e.g., wood, dung, or agricultural crop waste) with liquefied petroleum gas (LPG) for cooking does not affect...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.